Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07278388 · ClinicalTrials.gov registry record · NA

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

A NA study of Fatigue and PASC Post Acute Sequelae of COVID 19, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT07278388 is a NA study of Fatigue and PASC Post Acute Sequelae of COVID 19 that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 200 participants, roughly in line with the 216-participant average among 109 other Fatigue trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07278388, a NA study of Fatigue and PASC Post Acute Sequelae of COVID 19, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.

Interventions

  • BEHAVIORAL Physical Fatigue

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-07-16
Est. Completion 2029-12-31
Phase NA

What the Registry Record Tells You About NCT07278388

The ClinicalTrials.gov registry entry for NCT07278388 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 216-participant average among 109 other Fatigue trials with a reported enrollment target. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which Physical Fatigue is the first listed.

NCT07278388 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT07278388 about?

NCT07278388 is a clinical study titled "Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2". This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individu...

What is the current status of trial NCT07278388?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-07-16. Estimated completion is 2029-12-31.

What conditions does trial NCT07278388 study?

This clinical trial studies the following conditions: Fatigue, PASC Post Acute Sequelae of COVID 19.

What interventions are being tested in trial NCT07278388?

The interventions under investigation include: Physical Fatigue (BEHAVIORAL).

Who is sponsoring clinical trial NCT07278388?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07278388 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.